We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

CDC's HIV Prevention Patents Invalid, Gilead CEO Tells House

Law360 (May 16, 2019, 9:36 PM EDT) -- Gilead believes that Centers for Disease Control and Prevention patents that went toward its blockbuster HIV prevention and treatment medication Truvada are invalid and can't be used to make the company...
To view the full article, register now.